— Know what they know.
Not Investment Advice

VYGR NASDAQ

Voyager Therapeutics, Inc.
1W: -13.2% 1M: -11.1% 3M: +5.4% YTD: -8.7% 1Y: +8.2% 3Y: -67.6% 5Y: -19.3%
$3.80
+0.12 (+3.26%)
 
Weekly Expected Move ±8.8%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 26 · $229.6M mcap · 50M float · 1.37% daily turnover · Short 49% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.3 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -278.6%  ·  5Y Avg: -63.6%
Cost Advantage
42
Intangibles
48
Switching Cost
23
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VYGR has No discernible competitive edge (35.3/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. Negative ROIC of -278.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 17Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-03-12 Wells Fargo Yanan Zhu $14 $10 -4 +162.8% $3.81
2024-11-13 Oppenheimer Jay Olson Initiated $18 +160.1% $6.92
2024-09-25 Robert W. Baird Jack Allen Initiated $18 +198.0% $6.04
2024-05-14 Wedbush Laura Chico Initiated $8 -5.7% $8.48
2024-01-02 Wells Fargo Jim Birchenough Initiated $14 +55.6% $9.00
2023-05-10 Truist Financial Joon Lee Initiated $18 +82.2% $9.88

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VYGR receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-22 C- C
2026-04-01 C C-
2026-03-10 C+ C
2026-03-09 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

12 Grade D
Profitability
19
Balance Sheet
83
Earnings Quality
71
Growth
12
Value
40
Momentum
20
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. VYGR scores highest in Balance Sheet (83/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.67
Distress Zone
Piotroski F-Score
1/9
Beneish M-Score
-3.24
Unlikely Manipulator
Ohlson O-Score
-3.21
Bankruptcy prob: 3.9%
Low Risk
Credit Rating
BB
Score: 43.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 1.10x
Accruals: 3.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VYGR scores -0.67, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VYGR scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. VYGR's score of -3.24 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VYGR's implied 3.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VYGR receives an estimated rating of BB (score: 43.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.94x
PEG
0.06x
P/S
6.29x
P/B
1.30x
P/FCF
-1.77x
P/OCF
EV/EBITDA
-0.58x
EV/Revenue
1.91x
EV/EBIT
-0.56x
EV/FCF
-0.54x
Earnings Yield
-50.79%
FCF Yield
-56.58%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. VYGR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.001
NI / EBT
×
Interest Burden
0.935
EBT / EBIT
×
EBIT Margin
-3.415
EBIT / Rev
×
Asset Turnover
0.113
Rev / Assets
×
Equity Multiplier
1.301
Assets / Equity
=
ROE
-47.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VYGR's ROE of -47.0% is driven by Asset Turnover (0.113), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.80
Median 1Y
$2.29
5th Pctile
$0.67
95th Pctile
$7.91
Ann. Volatility
75.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Alfred Sandrock, M.D.,
Ph.D. Chief Executive Officer, President, and Director
$674,903 $611,900 $2,508,370
Jacquelyn Fahey Sandell
Former Chief Legal Officer
$297,842 $175,130 $1,474,986
Robin Swartz Business
siness Officer & Chief Operating Officer
$520,190 $300,675 $1,454,300
Toby Ferguson, M.D.,
Ph.D. Former Chief Medical Officer
$513,369 $265,860 $1,364,420

CEO Pay Ratio

9:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,508,370
Avg Employee Cost (SGA/emp): $266,270
Employees: 141

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
141
-18.0% YoY
Revenue / Employee
$286,340
Rev: $40,374,000
Profit / Employee
$-849,085
NI: $-119,721,000
SGA / Employee
$266,270
Avg labor cost proxy
R&D / Employee
$955,135
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 14.1% -73.1% -57.1% -56.8% -48.0% -13.7% -60.2% 1.3% 1.2% 67.9% 89.6% -2.1% 6.1% 17.5% -24.3% -31.6% -40.3% -47.3% -48.3% -47.0% -47.05%
ROA 5.8% -30.1% -31.3% -31.1% -26.3% -7.5% -26.3% 56.0% 54.3% 29.6% 51.8% -1.2% 3.5% 10.1% -17.5% -22.8% -29.0% -34.1% -37.1% -36.1% -36.15%
ROIC 31.9% -3.9% -8.7% -8.2% -7.1% -2.4% 1.1% -2.5% -2.4% -1.2% 4.7% -52.3% -23.2% 34.1% -85.7% -1.0% -1.3% -1.4% -2.9% -2.8% -2.79%
ROCE 2.8% -43.9% -51.5% -48.6% -42.1% -14.4% -58.6% 1.1% 1.0% 50.0% 43.6% -4.8% -0.3% 5.1% -23.5% -28.9% -35.9% -40.0% -57.2% -55.2% -55.21%
Gross Margin -13.4% -11.1% 50.1% -20.8% -16.6% 52.9% 10.4% 87.7% -3.5% -4.6% 98.5% 93.9% -8.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 64.1% 64.06%
Operating Margin -21.1% -17.0% 20.3% -32.4% -27.2% 35.2% 15.8% 81.7% -5.2% -6.4% 60.0% -82.9% -50.8% -56.0% -6.1% -5.4% -7.0% -2.3% -2.0% -11.7% -11.67%
Net Margin -22.2% -17.0% 20.3% -32.4% -26.8% 42.9% 15.2% 82.4% -4.6% -5.6% 62.6% -58.1% -34.3% -36.7% -5.5% -4.8% -6.4% -2.1% -1.8% -10.8% -10.77%
EBITDA Margin -20.2% -16.1% 25.6% -28.2% -25.5% 38.4% 15.3% 82.4% -5.0% -6.2% 65.0% -76.8% -37.6% -51.4% -5.9% -5.2% -6.8% -2.0% -1.9% -11.3% -11.31%
FCF Margin -75.6% -5.8% -1.5% 2.9% 13.4% 12.8% -36.7% 38.6% 46.9% 54.3% 29.9% 6.9% -15.5% -17.5% -23.5% -1.7% -2.7% -3.8% -3.3% -3.6% -3.56%
OCF Margin -68.6% -5.5% -1.4% 7.0% 20.8% 15.5% -30.6% 40.2% 48.4% 56.5% 31.2% 11.0% -12.3% -15.0% -19.1% -1.7% -2.7% -3.7% -3.3% -3.5% -3.51%
ROE 3Y Avg snapshot only -29.68%
ROE 5Y Avg snapshot only 0.82%
ROA 3Y Avg snapshot only -22.88%
ROIC 3Y Avg snapshot only -1.09%
ROIC Economic snapshot only -43.42%
Cash ROA snapshot only -50.73%
Cash ROIC snapshot only -3.54%
CROIC snapshot only -3.60%
NOPAT Margin snapshot only -2.76%
Pretax Margin snapshot only -3.19%
R&D / Revenue snapshot only 3.50%
SGA / Revenue snapshot only 99.10%
SBC / Revenue snapshot only 37.27%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 8.66 -1.07 -1.44 -4.09 -3.78 -13.72 -5.07 3.28 5.20 6.50 2.88 -174.69 50.60 13.08 -5.06 -2.33 -1.69 -2.17 -1.93 -1.97 -1.938
P/S Ratio 1.17 6.26 2.74 9.18 7.32 3.32 5.75 1.70 2.56 2.15 1.52 4.47 3.18 2.07 4.11 2.95 4.28 8.77 5.71 6.29 6.291
P/B Ratio 1.01 0.64 1.08 3.05 2.38 2.46 3.98 5.51 8.44 5.76 1.61 2.25 1.93 1.43 1.10 0.66 0.61 0.92 1.18 1.17 1.302
P/FCF -1.55 -1.09 -1.86 314.12 54.69 25.96 -15.68 4.41 5.45 3.95 5.10 64.59 -20.50 -11.81 -17.46 -1.73 -1.58 -2.31 -1.71 -1.77 -1.767
P/OCF 132.09 35.22 21.43 4.24 5.29 3.80 4.88 40.53
EV/EBITDA 1.95 0.35 -0.21 -3.22 -2.58 -10.62 -3.12 2.34 4.39 5.16 1.31 -34.40 63.57 6.46 -1.39 0.27 0.34 -0.39 -0.57 -0.58 -0.578
EV/Revenue 0.16 -2.15 0.38 6.39 4.46 2.07 3.41 1.20 2.07 1.54 0.68 2.70 1.71 0.78 1.32 -0.38 -0.95 1.65 1.75 1.91 1.910
EV/EBIT 3.27 0.33 -0.19 -2.91 -2.29 -7.09 -2.74 2.46 4.61 5.63 1.36 -23.11 -246.49 8.68 -1.31 0.26 0.33 -0.38 -0.55 -0.56 -0.559
EV/FCF -0.22 0.37 -0.26 218.39 33.34 16.17 -9.29 3.11 4.41 2.84 2.28 39.01 -11.05 -4.46 -5.62 0.23 0.35 -0.43 -0.52 -0.54 -0.536
Earnings Yield 11.5% -93.4% -69.5% -24.4% -26.4% -7.3% -19.7% 30.4% 19.2% 15.4% 34.8% -0.6% 2.0% 7.6% -19.8% -42.9% -59.2% -46.2% -51.9% -50.8% -50.79%
FCF Yield -64.5% -92.1% -53.8% 0.3% 1.8% 3.9% -6.4% 22.7% 18.3% 25.3% 19.6% 1.5% -4.9% -8.5% -5.7% -57.8% -63.5% -43.3% -58.6% -56.6% -56.58%
PEG Ratio snapshot only 0.058
Price/Tangible Book snapshot only 1.171
EV/Gross Profit snapshot only 1.960
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.39 7.39 2.68 2.68 2.68 2.68 1.72 1.72 1.72 1.72 4.96 4.96 4.96 4.96 5.56 5.56 5.56 5.56 7.64 7.64 7.637
Quick Ratio 7.39 7.39 2.68 2.68 2.68 2.68 1.72 1.72 1.72 1.72 4.96 4.96 4.96 4.96 5.56 5.56 5.56 5.56 7.64 7.64 7.637
Debt/Equity 0.31 0.31 0.46 0.46 0.46 0.46 0.39 0.39 0.39 0.39 0.09 0.09 0.09 0.09 0.15 0.15 0.15 0.15 0.19 0.19 0.186
Net Debt/Equity -0.87 -0.87 -0.93 -0.93 -0.93 -0.93 -1.62 -1.62 -1.62 -1.62 -0.89 -0.89 -0.89 -0.89 -0.74 -0.74 -0.74 -0.74 -0.82 -0.82 -0.816
Debt/Assets 0.18 0.18 0.23 0.23 0.23 0.23 0.15 0.15 0.15 0.15 0.06 0.06 0.06 0.06 0.11 0.11 0.11 0.11 0.14 0.14 0.145
Debt/EBITDA 4.28 -0.48 -0.65 -0.70 -0.83 -3.22 -0.52 0.24 0.25 0.49 0.16 -2.17 5.24 1.03 -0.57 -0.46 -0.37 -0.33 -0.29 -0.30 -0.302
Net Debt/EBITDA -12.00 1.36 1.29 1.41 1.65 6.43 2.14 -0.98 -1.04 -2.02 -1.62 22.55 -54.41 -10.64 2.93 2.35 1.87 1.67 1.28 1.33 1.326
Interest Coverage -114.49 -107.90 -93.56 -32.00
Equity Multiplier 1.70 1.70 2.04 2.04 2.04 2.04 2.70 2.70 2.70 2.70 1.49 1.49 1.49 1.49 1.31 1.31 1.31 1.31 1.29 1.29 1.287
Cash Ratio snapshot only 7.402
Cash to Debt snapshot only 5.382
FCF to Debt snapshot only -3.560
Defensive Interval snapshot only 443.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.43 0.05 0.16 0.14 0.14 0.31 0.23 1.08 1.10 0.90 0.98 0.47 0.56 0.64 0.21 0.18 0.11 0.08 0.13 0.11 0.113
Inventory Turnover 80.73 74.26
Receivables Turnover 9.98 1.20 8.56 7.22 7.07 16.13 59.67 278.23 284.27 231.07 6.19 2.95 3.56 4.05 1.96 1.64 1.04 0.77 24.73 22.35 22.355
Payables Turnover 37.79 34.76 122.16 108.92 97.37 99.72 38.70 41.39 47.41 51.57 32.49 24.16 28.94 16.54 11.84 11.41 0.00 0.00 0.00 0.21 0.207
DSO 37 305 43 51 52 23 6 1 1 2 59 124 103 90 186 223 350 476 15 16 16.3 days
DIO 5 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 10 10 3 3 4 4 9 9 8 7 11 15 13 22 31 32 1764 1764.1 days
Cash Conversion Cycle 31 299 40 47 48 19 -3 -8 -6 -5 48 109 90 68 155 191 -1748 -1747.8 days
Fixed Asset Turnover snapshot only 0.877
Cash Velocity snapshot only 0.186
Capital Intensity snapshot only 6.913
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 32.4% -92.0% -78.1% -80.2% -76.6% 3.4% 9.3% 5.0% 5.3% 1.2% 5.1% -37.6% -26.2% 3.4% -68.0% -43.8% -70.4% -80.9% -49.5% -45.5% -45.50%
Net Income 1.3% -3.3% -2.9% -2.8% -4.3% 81.6% 34.8% 2.4% 2.6% 4.1% 3.9% -1.0% -90.6% -50.5% -1.5% -26.8% -13.0% -5.9% -84.2% -37.7% -37.72%
EPS 1.3% -3.3% -2.9% -2.8% -4.3% 82.4% 36.1% 2.3% 2.4% 3.8% 3.4% -1.0% -92.9% -62.5% -1.4% -26.2% -12.8% -5.8% -81.9% -35.1% -35.06%
FCF 2.8% 16.8% 49.3% 1.0% 1.0% 1.1% 72.8% 78.8% 21.1% 8.5% 6.0% -88.8% -1.2% -1.3% -1.3% -14.8% -4.2% -3.1% -6.2% -14.0% -13.98%
EBITDA 1.2% -3.4% -3.2% -3.1% -5.8% 86.0% 34.8% 2.6% 2.7% 4.4% 3.9% -1.1% -95.8% -58.2% -1.6% -9.1% -31.8% -7.7% -64.4% -27.3% -27.35%
Op. Income 1.1% -3.8% -3.7% -3.6% -10.1% 80.0% 30.9% 2.3% 2.5% 3.1% 3.4% -1.2% -1.1% -79.1% -1.7% -5.0% -17.6% -16.5% -58.3% -25.2% -25.17%
OCF Growth snapshot only -14.31%
Asset Growth snapshot only -35.81%
Equity Growth snapshot only -34.59%
Debt Growth snapshot only -16.53%
Shares Change snapshot only 1.96%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.3% 9.9% 70.0% 38.5% -17.7% -1.5% -26.8% 17.6% 25.0% -7.1% 13.5% -9.3% 2.8% 1.2% 28.8% 28.5% 11.2% -23.7% -0.4% -42.4% -42.38%
Revenue 5Y 57.9% -1.1% 21.3% 23.8% 30.1% 62.9% 32.2% 81.8% 77.7% 67.7% 1.0% 58.6% 21.0% 17.3% -5.2% -10.6% -15.7% -30.8% -25.1% -25.6% -25.55%
EPS 3Y 3.9% 44.0% -31.0%
EPS 5Y
Net Income 3Y 9.3% 53.3% -20.4%
Net Income 5Y
EBITDA 3Y 5.0% 60.8% -29.7%
EBITDA 5Y
Gross Profit 3Y 1.5% 43.0% 4.2% 24.4% 44.9% -34.4% -34.36%
Gross Profit 5Y -15.8% -8.3% -10.2% -10.16%
Op. Income 3Y 5.1% 64.6%
Op. Income 5Y
FCF 3Y -74.7% -55.5% -40.5%
FCF 5Y -32.1%
OCF 3Y -66.9% -50.1% -38.8%
OCF 5Y 1.2% -26.4%
Assets 3Y 12.3% 12.3% 3.1% 3.1% 3.1% 3.1% -23.4% -23.4% -23.4% -23.4% 10.3% 10.3% 10.3% 10.3% 26.6% 26.6% 26.6% 26.6% 16.5% 16.5% 16.55%
Assets 5Y 2.7% 2.7% 0.4% 0.4% 0.4% 0.4% -2.9% -2.9% -2.9% -2.9% 14.7% 14.7% 14.7% 14.7% 2.1% 2.1% 2.1% 2.1% -0.7% -0.7% -0.72%
Equity 3Y 4.8% 4.8% 27.0% 27.0% 27.0% 27.0% -16.0% -16.0% -16.0% -16.0% 15.3% 15.3% 15.3% 15.3% 46.6% 46.6% 46.6% 46.6% 49.2% 49.2% 49.21%
Book Value 3Y -0.7% -0.6% 20.5% 21.5% 26.6% 23.9% -17.2% -19.6% -20.4% -20.1% 8.3% 0.2% -0.1% 0.0% 27.2% 27.2% 27.2% 28.5% 29.7% 33.0% 33.03%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.84 0.14 0.24 0.22 0.21 0.06 0.01 0.37 0.44 0.14 0.31 0.31 0.33 0.50 0.06 0.00 0.00 0.34 0.15 0.72 0.718
Earnings Stability 0.12 0.01 0.06 0.11 0.20 0.13 0.09 0.51 0.57 0.30 0.40 0.32 0.39 0.23 0.02 0.02 0.01 0.09 0.12 0.36 0.358
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.00 0.64 0.645
Rev. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.20 0.50 0.20 0.20 0.50 0.85 0.849
Earnings Smoothness 0.00 0.32
ROE Trend 1.05 -0.23 -0.65 -0.67 -0.38 -0.08 -0.53 1.92 1.88 1.28 1.33 -0.48 -0.46 -0.24 -0.10 -1.11 -1.19 -0.92 -0.78 -0.45 -0.447
Gross Margin Trend 0.72 -4.18 -1.10 -1.25 -0.92 2.03 -0.18 1.01 0.90 2.49 1.46 0.79 0.72 0.47 0.46 -0.10 0.40 0.36 0.34 0.42 0.425
FCF Margin Trend -0.67 -5.78 -1.35 0.83 1.03 3.29 0.69 0.69 0.78 3.36 1.22 -0.14 -0.46 -0.51 -0.20 -1.93 -2.88 -3.98 -3.38 -2.74 -2.744
Sustainable Growth Rate 14.1% 1.3% 1.2% 67.9% 89.6% 6.1% 17.5%
Internal Growth Rate 6.2% 1.3% 1.2% 42.1% 1.1% 3.7% 11.3%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -5.06 0.93 0.75 -0.03 -0.11 -0.64 0.27 0.77 0.98 1.71 0.59 -4.31 -1.95 -0.95 0.24 1.32 1.05 0.92 1.11 1.10 1.097
FCF/OCF 1.10 1.06 1.03 0.42 0.64 0.83 1.20 0.96 0.97 0.96 0.96 0.63 1.26 1.17 1.23 1.02 1.02 1.02 1.02 1.02 1.015
FCF/Net Income snapshot only 1.114
CapEx/Revenue 7.0% 30.3% 4.3% 4.0% 7.4% 2.7% 6.1% 1.6% 1.5% 2.2% 1.3% 4.1% 3.2% 2.5% 4.4% 3.0% 5.1% 6.8% 6.4% 5.3% 5.35%
CapEx/Depreciation snapshot only 0.491
Accruals Ratio 0.35 -0.02 -0.08 -0.32 -0.29 -0.12 -0.19 0.13 0.01 -0.21 0.21 -0.06 0.10 0.20 -0.13 0.07 0.02 -0.03 0.04 0.04 0.035
Sloan Accruals snapshot only -0.170
Cash Flow Adequacy snapshot only -65.569
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.9% -0.9% -0.6% -0.2% -0.5% -0.4% -0.5% -9.9% -6.3% -9.2% -8.3% -21.3% -24.8% -33.5% -34.3% 0.0% -0.3% -0.2% -0.3% -1.8% -1.77%
Total Shareholder Return -0.9% -0.9% -0.6% -0.2% -0.5% -0.4% -0.5% -9.9% -6.3% -9.2% -8.3% -21.3% -24.8% -33.5% -34.3% 0.0% -0.3% -0.2% -0.3% -1.8% -1.77%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.98 0.99 1.54 0.90 0.97 1.01 1.01 1.01 1.01 1.00 1.00 1.001
Interest Burden (EBT/EBIT) 2.70 0.90 0.97 1.02 0.99 0.83 0.91 1.07 1.11 1.23 1.07 0.14 -10.08 1.82 0.80 0.85 0.87 0.92 0.93 0.93 0.935
EBIT Margin 0.05 -6.49 -1.97 -2.20 -1.95 -0.29 -1.24 0.49 0.45 0.27 0.50 -0.12 -0.01 0.09 -1.01 -1.48 -2.90 -4.39 -3.20 -3.42 -3.415
Asset Turnover 0.43 0.05 0.16 0.14 0.14 0.31 0.23 1.08 1.10 0.90 0.98 0.47 0.56 0.64 0.21 0.18 0.11 0.08 0.13 0.11 0.113
Equity Multiplier 2.43 2.43 1.83 1.83 1.83 1.83 2.29 2.29 2.29 2.29 1.73 1.73 1.73 1.73 1.39 1.39 1.39 1.39 1.30 1.30 1.301
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.48 $-2.46 $-1.88 $-1.86 $-1.56 $-0.43 $-1.20 $2.35 $2.20 $1.19 $2.94 $-0.05 $0.16 $0.45 $-1.12 $-1.45 $-1.84 $-2.16 $-2.04 $-1.96 $-1.96
Book Value/Share $4.11 $4.08 $2.51 $2.50 $2.48 $2.40 $1.53 $1.40 $1.36 $1.35 $5.24 $4.14 $4.09 $4.08 $5.17 $5.14 $5.11 $5.10 $3.34 $3.30 $2.92
Tangible Book/Share $4.11 $4.08 $2.51 $2.50 $2.48 $2.40 $1.53 $1.40 $1.36 $1.35 $5.24 $4.14 $4.09 $4.08 $5.17 $5.14 $5.11 $5.10 $3.34 $3.30 $3.30
Revenue/Share $3.52 $0.42 $0.99 $0.83 $0.81 $1.78 $1.06 $4.52 $4.48 $3.61 $5.55 $2.08 $2.49 $2.83 $1.38 $1.15 $0.73 $0.53 $0.69 $0.61 $0.61
FCF/Share $-2.66 $-2.42 $-1.46 $0.02 $0.11 $0.23 $-0.39 $1.75 $2.10 $1.96 $1.66 $0.14 $-0.39 $-0.50 $-0.32 $-1.95 $-1.97 $-2.02 $-2.30 $-2.18 $-2.18
OCF/Share $-2.41 $-2.29 $-1.42 $0.06 $0.17 $0.28 $-0.32 $1.82 $2.17 $2.04 $1.73 $0.23 $-0.31 $-0.42 $-0.26 $-1.92 $-1.94 $-1.99 $-2.26 $-2.15 $-2.15
Cash/Share $4.82 $4.79 $3.51 $3.48 $3.46 $3.35 $3.08 $2.82 $2.73 $2.71 $5.12 $4.04 $4.00 $3.99 $4.60 $4.57 $4.55 $4.54 $3.35 $3.30 $2.38
EBITDA/Share $0.30 $-2.60 $-1.81 $-1.65 $-1.40 $-0.35 $-1.16 $2.32 $2.11 $1.08 $2.88 $-0.16 $0.07 $0.34 $-1.31 $-1.62 $-2.03 $-2.27 $-2.13 $-2.03 $-2.03
Debt/Share $1.27 $1.26 $1.17 $1.16 $1.15 $1.12 $0.60 $0.55 $0.53 $0.53 $0.45 $0.36 $0.35 $0.35 $0.75 $0.75 $0.75 $0.74 $0.62 $0.61 $0.61
Net Debt/Share $-3.55 $-3.53 $-2.34 $-2.32 $-2.31 $-2.23 $-2.48 $-2.27 $-2.20 $-2.18 $-4.67 $-3.69 $-3.65 $-3.64 $-3.85 $-3.82 $-3.80 $-3.79 $-2.73 $-2.69 $-2.69
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -0.670
Altman Z-Prime snapshot only -0.211
Piotroski F-Score 4 2 2 2 2 5 3 5 5 5 6 5 4 4 4 3 3 3 1 1 1
Beneish M-Score 0.89 11.99 -3.86 -6.85 -5.53 8.24 187.42 3.99 -0.49 932.01 44.25 21.07 9.05 11.21 9.98 11.20 -2.14 -3.24 -3.236
Ohlson O-Score snapshot only -3.208
ROIC (Greenblatt) snapshot only -57.24%
Net-Net WC snapshot only $2.46
EVA snapshot only $-104275890.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 50.39 40.16 28.82 32.52 34.32 36.85 40.39 80.28 84.32 69.85 91.30 74.30 57.42 72.66 49.60 50.10 44.36 49.52 44.03 43.66 43.664
Credit Grade snapshot only 12
Credit Trend snapshot only -6.437
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms